These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6549013)

  • 1. Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors.
    Takebe S; Numata A; Kobashi K
    J Clin Microbiol; 1984 Nov; 20(5):869-73. PubMed ID: 6549013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureaplasma urealyticum-induced crystallization of magnesium ammonium phosphate and calcium phosphates in synthetic urine.
    Grenabo L; Brorson JE; Hedelin H; Pettersson S
    J Urol; 1984 Oct; 132(4):795-9. PubMed ID: 6381769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary calculi and infection].
    Trinchieri A
    Urologia; 2014; 81(2):93-8. PubMed ID: 24874306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
    Satoh M; Munakata K; Kitoh K; Seto N; Kanazawa T; Takeuchi H; Yoshida O
    J Pharmacobiodyn; 1981 Jul; 4(7):469-74. PubMed ID: 7028944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary infection stones caused by Ureaplasma urealyticum: a review.
    Grenabo L; Hedelin H; Pettersson S
    Scand J Infect Dis Suppl; 1988; 53():46-9. PubMed ID: 3047857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ureaplasma urealyticum as a causative organism of urinary tract infection stones.
    Mobarak A; Tharwat A
    J Egypt Public Health Assoc; 1996; 71(3-4):309-19. PubMed ID: 17217015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.
    Nagata K; Takagi E; Satoh H; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2187-92. PubMed ID: 8619564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureaplasma-urealyticum-induced bladder stones in rats and their prevention by flurofamide and doxycycline.
    Texier-Maugein J; Clerc M; Vekris A; Bebear C
    Isr J Med Sci; 1987 Jun; 23(6):565-7. PubMed ID: 3667226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the growth of Ureaplasma urealyticum by a new urease inhibitor, flurofamide.
    Kenny GE
    Yale J Biol Med; 1983; 56(5-6):717-22. PubMed ID: 6679152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of urease from Ureaplasma urealyticum.
    Saada AB; Kahane I
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Aug; 269(2):160-7. PubMed ID: 3195254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental bladder stone production by Ureaplasma urealyticum].
    Arai Y; Takeuchi H; Okada Y; Tomoyoshi T
    Hinyokika Kiyo; 1996 Oct; 42(10):729-34. PubMed ID: 8951464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical changes of urine environment on propionhydroxamic acid therapy.
    Bruno M; Marangella M; Tricerri A; Martini C; Linari F
    Contrib Nephrol; 1987; 58():207-11. PubMed ID: 3691128
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.
    Takeuchi H; Kobashi K; Yoshida O
    Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Ureaplasma urealyticum urease.
    Blanchard A; Razin S; Kenny GE; Barile MF
    J Bacteriol; 1988 Jun; 170(6):2692-7. PubMed ID: 3131306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skene's gland calculi produced by a Ureaplasma urealyticum infection.
    Gellman AC; Dershewitz D
    J Urol; 1986 Apr; 135(4):786-8. PubMed ID: 3959204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concrement formation in the urinary bladder in rats inoculated with Ureaplasma urealyticum.
    Grenabo L; Brorson JE; Hedelin H; Pettersson S
    Urol Res; 1985; 13(4):195-8. PubMed ID: 4049607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental magnesium ammonium phosphate lithiasis induced by Ureaplasma in the rat].
    Texier J; Clerc MT; Bébéar C; Aparicio M; Clerc M; Potaux L
    Nephrologie; 1984; 5(5):222-4. PubMed ID: 6531060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection stones and the role of bacterial urease.
    Rosenstein I; Hamilton-Miller JM; Brumfitt W
    J Infect; 1980 Sep; 2(3):211-4. PubMed ID: 6764484
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of anti-Ureaplasma urease antibody on homologous and heterologous urease activities.
    Eng H; Robertson JA; Stemke GW
    Microbios; 1987; 49(198):47-54. PubMed ID: 2436028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of enzymes in Ureaplasma urealyticum (T-strain mycoplasma).
    Masover GK; Razin S; Hayflick L
    J Bacteriol; 1977 Apr; 130(1):297-302. PubMed ID: 15980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.